Primecap Management Co. CA trimmed its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 11.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,197,983 shares of the biopharmaceutical company’s stock after selling 951,893 shares during the period. Primecap Management […]
Related Keywords
United States , , Nektar Therapeutics , Primecap Management Co , Syntax Advisors , Life Insurance Co , Jpmorgan Chase Co , Tower Research Capital , Exchange Commission , Primecap Management , Free Report , Advocates Investment Management , Research Capital , Therapeutics Trading Down , Nektar Therapeutics Daily , Nasdaq Nktr , Nktr , Medical , 64026810 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,
vimarsana.com © 2020. All Rights Reserved.